ClearanceBrief
Recall Z-2095-2017 ยท JWY Manual Antimicrobial Susceptibility Test Systems

BioMerieux SA

ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States)

DateMay 3, 2017 (initiated Apr 25, 2017)
StatusTerminated
ReasonFalse susceptible results
Root causeUnder Investigation by firm
ActionbioMerieux sent an Urgent Product Safety Correction Notice on April 25, 2017 to U. S. consignees. The letter requested that they provide the notice to all appropriate personnel in the laboratory, asking them to identify any possible False Susceptible results. The letter included a Acknowledgment Form to be returned. On this notice the consignee will indicate the number of kits discarded. For customers with questions please contact their local bioMerieux Customer Service representative.
Quantity3,238 units
DistributionNATIONWIDE DISTRIBUTION TO AL, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, IL, IN, IA, KS, KY, LA, M, MA, MD, MI, MN, MS, MO, MT, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K020748ETEST ERTAPENEM
Ab Biodisk, Apr 29, 2002